Suzuki Shohei, Goto Mio, Okamoto Takahide, Tomita Ichiro, Murayama Akihiro, Sawa Masayuki, Noguchi Yoshikazu, Hoshikawa Yoshikazu, Shimizu Akio
Department of Surgery, Shonantobu General Hospital, Japan.
Gan To Kagaku Ryoho. 2010 Jan;37(1):123-6.
The patient was a 63-year-old male admitted for further evaluation of the bleeding esophageal tumor. Endoscopic biopsy revealed small cell carcinoma. CT scan of the abdomen demonstrated nodular enlargement at the celiac axis. Under diagnosis of small cell carcinoma of the esophagus at Stage IVa, neoadjuvant chemotherapy with FP (5-FU+CDDP) was given. Immediately after fluid load, levels of serum sodium decreased to 117 mEq/L and persisted during chemotherapy treatment despite aggressive corrections. Response and shrinkage of the distant nodal metastases were confirmed, and an esophagectomy was conducted. Pathological examination with IHC demonstrated positive staining for CD56, NSE and synaptophysin but negative for ADH. Lymph node and liver metastases recurred. Progression of the disease again triggered hyponatremia.
该患者为一名63岁男性,因食管肿瘤出血入院进一步评估。内镜活检显示为小细胞癌。腹部CT扫描显示腹腔干轴处有结节状肿大。在诊断为IVa期食管小细胞癌后,给予FP(5-氟尿嘧啶+顺铂)新辅助化疗。补液后,血清钠水平立即降至117 mEq/L,且在化疗期间尽管积极纠正仍持续下降。远处淋巴结转移灶有反应并缩小,随后进行了食管切除术。免疫组化病理检查显示CD56、神经元特异性烯醇化酶(NSE)和突触素染色阳性,但抗利尿激素(ADH)染色阴性。淋巴结和肝转移复发。疾病进展再次引发低钠血症。